These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15098869)
1. Correlation of second-trimester sonographic and biochemical markers. Souter VL; Nyberg DA; Benn PA; Zebelman A; Luthardt F; Luthy DA J Ultrasound Med; 2004 Apr; 23(4):505-11. PubMed ID: 15098869 [TBL] [Abstract][Full Text] [Related]
2. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888 [TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
5. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763 [TBL] [Abstract][Full Text] [Related]
6. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718 [TBL] [Abstract][Full Text] [Related]
7. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age. Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608 [TBL] [Abstract][Full Text] [Related]
8. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes]. Hu Z; Liu X; Li L; Jia C; Li D; Liu R Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246 [TBL] [Abstract][Full Text] [Related]
9. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. Nyberg DA; Souter VL; El-Bastawissi A; Young S; Luthhardt F; Luthy DA J Ultrasound Med; 2001 Oct; 20(10):1053-63. PubMed ID: 11587012 [TBL] [Abstract][Full Text] [Related]
10. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies. Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908 [TBL] [Abstract][Full Text] [Related]
11. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343 [TBL] [Abstract][Full Text] [Related]
12. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results. Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387 [TBL] [Abstract][Full Text] [Related]
13. Genetic sonography after first-trimester Down syndrome screening. Krantz DA; Hallahan TW; Macri VJ; Macri JN Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748 [TBL] [Abstract][Full Text] [Related]
15. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Burton BK; Prins GS; Verp MS Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522 [TBL] [Abstract][Full Text] [Related]
16. The comprehensive midtrimester test: high-sensitivity Down syndrome test. Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511 [TBL] [Abstract][Full Text] [Related]
17. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Vintzileos AM; Egan JF Am J Obstet Gynecol; 1995 Mar; 172(3):837-44. PubMed ID: 7892872 [TBL] [Abstract][Full Text] [Related]
18. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome. Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756 [TBL] [Abstract][Full Text] [Related]
19. Sonographic markers of fetal trisomies: second trimester. Nyberg DA; Souter VL J Ultrasound Med; 2001 Jun; 20(6):655-74. PubMed ID: 11400940 [TBL] [Abstract][Full Text] [Related]
20. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies. Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]